Deep learning for continuous manufacturing of pharmaceutical solid dosage form

被引:25
|
作者
Roggo, Yves [1 ]
Jelsch, Morgane [1 ]
Heger, Philipp [1 ]
Ensslin, Simon [1 ]
Krumme, Markus [1 ]
机构
[1] Novartis Pharma AG, Continuous Mfg CM Unit, WSJ 27-4-021-01, CH-4002 Basel, Switzerland
关键词
Continuous manufacturing; Solid dosage form; Process monitoring; Process analytical technology; Deep learning; Process data science; Process data analytics; PROCESS ANALYTICAL TECHNOLOGY;
D O I
10.1016/j.ejpb.2020.06.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Continuous Manufacturing (CM) of pharmaceutical drug products is a new approach within the pharmaceutical industry. In the presented paper, a GMP continuous wet granulation line for production of solid dosage forms was investigated. The line was composed of the subsequent continuous unit operations feeding - twin-screw wet-granulation - fluid-bed drying - sieving and tableting. The formulation of a commercial entity was selected for this study. Several critical process parameters were evaluated in order to probe the process and to characterize the impact on quality attributes. Seven critical process parameters have been selected after a risk analysis: API and excipient mass flows of the two feeders, liquid feed rate and rotation speed of the extruder and rotation speed, temperature and airflow of the dryer. Eight quality attributes were controlled in real time by Process Analytical Technologies (PAT): API content after blender, after dryer, in tablet press feed frame and of tablet LOD after dryer and PSD after dryer (three PSD parameters: x10 x50 x90). The process parameter values were changed during production in order to detect the impact on the quality of the final product. The deep learning techniques have been used in order to predict the quality attribute (output) with the process parameters (input). The use of deep learning reduces the noise and simplify the data interpretation for a better process understanding. After optimization, three hidden layers neural network were selected with 6 hidden neurons. The activation function ReLU (Rectified Linear Unit) and the ADAM optimizer were used with 2500 epochs (number of learning cycle). API contents, PSD values and LOD values were estimated with an error of calibration lower than 10%. The level of error allow an adequate process monitoring by DNN and we have proven that the main critical process parameters can be identified at a higher levelof process understanding. The synergy between PAT and process data science creates a superior monitoring framework of the continuous manufacturing line and increase the knowledge of this innovative production line and the products that it makes.
引用
收藏
页码:95 / 105
页数:11
相关论文
共 50 条
  • [41] Recovery of Active Pharmaceutical Ingredients from Unused Solid Dosage-Form Drugs
    Pratama, Dhanang Edy
    Hsieh, Wen-Chen
    Elmaamoun, Ahmed
    Lee, Hung Lin
    Lee, Tu
    ACS OMEGA, 2020, 5 (45): : 29147 - 29157
  • [42] Investigation of Plantago ovata Husk as Pharmaceutical Excipient for Solid Dosage Form (Orodispersible Tablets)
    Abbas, Sarmad
    Sherazi, Mehrin
    Khan, Amjad
    Alyami, Hamad S.
    Latif, Muhammad
    Qureshi, Zia-Ur-Rahman
    Majeedullah
    Bin Asad, Muhammad Hassham Hassan
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [43] Optimizing solid dosage manufacturing
    Markarian, Jennifer
    Markarian, J., 1600, Advanstar Communications Inc. (38): : 24 - 28
  • [44] Continuous Manufacturing in the Pharmaceutical Industry
    Yazdanpanah, Nima
    CHEMICAL ENGINEERING PROGRESS, 2021, 117 (03) : 28 - 35
  • [45] Charting dosage-form manufacturing
    Bldg. F, 485 Route One South, Iselin, NJ 08830, United States
    Pharm. Technol., 2008, 2 (52-58):
  • [46] Lubricants in Pharmaceutical Solid Dosage Forms
    Li, Jinjiang
    Wu, Yongmei
    LUBRICANTS, 2014, 2 (01): : 21 - 43
  • [47] Modeling of Particulate Processes for the Continuous Manufacture of Solid-Based Pharmaceutical Dosage Forms
    Rogers, Amanda J.
    Hashemi, Amir
    Ierapetritou, Marianthi G.
    PROCESSES, 2013, 1 (02): : 67 - 127
  • [48] Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing
    Burcham, Christopher L.
    Florence, Alastair J.
    Johnson, Martin D.
    ANNUAL REVIEW OF CHEMICAL AND BIOMOLECULAR ENGINEERING, VOL 9, 2018, 9 : 253 - 281
  • [49] HPLC Analysis of Urapidil in Pharmaceutical Dosage Form
    Cai, Defu
    Zhang, Qi
    ASIAN JOURNAL OF CHEMISTRY, 2012, 24 (01) : 315 - 318
  • [50] Applications of Near Infrared Spectroscopy in the Full-Scale Manufacturing of Pharmaceutical Solid Dosage Forms
    Maurer, Lene
    Leuenberger, Hans
    PHARMAZEUTISCHE INDUSTRIE, 2009, 71 (04): : 672 - +